FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313591605> ?p ?o ?g. }

• W4313591605 endingPage "11" @default.
• W4313591605 startingPage "1" @default.
• W4313591605 abstract "Primary central nervous system lymphoma (PCNSL) usually has a poor prognosis. Cerebrospinal fluid (CSF) interleukin (IL)-10 has shown diagnostic, prognostic, and monitoring value in our previous studies. Cell-free circulating tumor DNA can be detected in the CSF of refractory/relapse cases and has also shown monitoring value. However, information about its monitoring value in newly diagnosed PCNSL patients and comparisons of CSF IL-10 and CSF cell-free DNA (cfDNA) are scarce.We performed next-generation sequencing on paraffin-embedded tissue and the serial CSF cfDNA of 10 newly diagnosed PCNSL patients and on the baseline CSF cfDNA of 11 other central nervous system lymphoma patients. We also monitored the CSF IL-10 levels of the 10 newly diagnosed PCNSL patients.In seven newly diagnosed PCNSL patients with sufficient baseline CSF cfDNA, six had ≥1 mutated genes in their CSF cfDNA. The most common were MYD88(4/7), PIM1(3/7), MLL2(3/7), and ETV6(2/7). We also identified multiple somatic mutations, most commonly in PIM1. MYD88L265P can be detected in both tumor tissue and CSF cfDNA. The genomic profiles of CFS cfDNA were similar in PCNSL and PIOL patients. Newly diagnosed PCNSL patients with persistently positive cfDNA and negative IL-10 progressed quickly, while those with negative cfDNA and negative IL-10 were in maintenance therapy for more than 18 months. Two patients without cfDNA had increased CSF IL-10 concentrations before disease relapse. These results indicate that negative CSF cfDNA predicts better results, and persistently positive CSF cfDNA predicts disease progression earlier than conventional magnetic resonance imaging.In conclusion, CSF cfDNA is a potential predictor of relapse and progression, which complements the monitoring value of CSF IL-10 in newly diagnosed PCNSL patients." @default.
• W4313591605 created "2023-01-06" @default.
• W4313591605 creator A5003339044 @default.
• W4313591605 creator A5026666161 @default.
• W4313591605 creator A5028108490 @default.
• W4313591605 creator A5038628251 @default.
• W4313591605 creator A5040248634 @default.
• W4313591605 creator A5045814990 @default.
• W4313591605 creator A5056582438 @default.
• W4313591605 creator A5057169234 @default.
• W4313591605 creator A5060764634 @default.
• W4313591605 creator A5061265927 @default.
• W4313591605 creator A5064794027 @default.
• W4313591605 creator A5070674661 @default.
• W4313591605 creator A5072101455 @default.
• W4313591605 creator A5080469344 @default.
• W4313591605 date "2023-01-04" @default.
• W4313591605 modified "2023-10-14" @default.
• W4313591605 title "Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma" @default.
• W4313591605 cites W1949176581 @default.
• W4313591605 cites W1989124191 @default.
• W4313591605 cites W2019795156 @default.
• W4313591605 cites W2099516399 @default.
• W4313591605 cites W2113971895 @default.
• W4313591605 cites W2117131162 @default.
• W4313591605 cites W2137816642 @default.
• W4313591605 cites W2149603266 @default.
• W4313591605 cites W2152683795 @default.
• W4313591605 cites W2237189228 @default.
• W4313591605 cites W2389545431 @default.
• W4313591605 cites W2560233848 @default.
• W4313591605 cites W2747106809 @default.
• W4313591605 cites W2753973628 @default.
• W4313591605 cites W2805418493 @default.
• W4313591605 cites W2889578361 @default.
• W4313591605 cites W2898779567 @default.
• W4313591605 cites W2899869326 @default.
• W4313591605 cites W2903669497 @default.
• W4313591605 cites W2941236117 @default.
• W4313591605 cites W2981705588 @default.
• W4313591605 cites W3008151329 @default.
• W4313591605 cites W3014018086 @default.
• W4313591605 cites W3121377087 @default.
• W4313591605 cites W4292492275 @default.
• W4313591605 doi "https://doi.org/10.1155/2023/5808731" @default.
• W4313591605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36644235" @default.
• W4313591605 hasPublicationYear "2023" @default.
• W4313591605 type Work @default.
• W4313591605 citedByCount "0" @default.
• W4313591605 crossrefType "journal-article" @default.
• W4313591605 hasAuthorship W4313591605A5003339044 @default.
• W4313591605 hasAuthorship W4313591605A5026666161 @default.
• W4313591605 hasAuthorship W4313591605A5028108490 @default.
• W4313591605 hasAuthorship W4313591605A5038628251 @default.
• W4313591605 hasAuthorship W4313591605A5040248634 @default.
• W4313591605 hasAuthorship W4313591605A5045814990 @default.
• W4313591605 hasAuthorship W4313591605A5056582438 @default.
• W4313591605 hasAuthorship W4313591605A5057169234 @default.
• W4313591605 hasAuthorship W4313591605A5060764634 @default.
• W4313591605 hasAuthorship W4313591605A5061265927 @default.
• W4313591605 hasAuthorship W4313591605A5064794027 @default.
• W4313591605 hasAuthorship W4313591605A5070674661 @default.
• W4313591605 hasAuthorship W4313591605A5072101455 @default.
• W4313591605 hasAuthorship W4313591605A5080469344 @default.
• W4313591605 hasBestOaLocation W43135916051 @default.
• W4313591605 hasConcept C121608353 @default.
• W4313591605 hasConcept C126322002 @default.
• W4313591605 hasConcept C142724271 @default.
• W4313591605 hasConcept C143998085 @default.
• W4313591605 hasConcept C152110520 @default.
• W4313591605 hasConcept C172680121 @default.
• W4313591605 hasConcept C2778258057 @default.
• W4313591605 hasConcept C2779234561 @default.
• W4313591605 hasConcept C2779338263 @default.
• W4313591605 hasConcept C2779529041 @default.
• W4313591605 hasConcept C2779651940 @default.
• W4313591605 hasConcept C2781173314 @default.
• W4313591605 hasConcept C54355233 @default.
• W4313591605 hasConcept C71924100 @default.
• W4313591605 hasConcept C86803240 @default.
• W4313591605 hasConcept C90924648 @default.
• W4313591605 hasConceptScore W4313591605C121608353 @default.
• W4313591605 hasConceptScore W4313591605C126322002 @default.
• W4313591605 hasConceptScore W4313591605C142724271 @default.
• W4313591605 hasConceptScore W4313591605C143998085 @default.
• W4313591605 hasConceptScore W4313591605C152110520 @default.
• W4313591605 hasConceptScore W4313591605C172680121 @default.
• W4313591605 hasConceptScore W4313591605C2778258057 @default.
• W4313591605 hasConceptScore W4313591605C2779234561 @default.
• W4313591605 hasConceptScore W4313591605C2779338263 @default.
• W4313591605 hasConceptScore W4313591605C2779529041 @default.
• W4313591605 hasConceptScore W4313591605C2779651940 @default.
• W4313591605 hasConceptScore W4313591605C2781173314 @default.
• W4313591605 hasConceptScore W4313591605C54355233 @default.
• W4313591605 hasConceptScore W4313591605C71924100 @default.
• W4313591605 hasConceptScore W4313591605C86803240 @default.
• W4313591605 hasConceptScore W4313591605C90924648 @default.
• W4313591605 hasFunder F4320321001 @default.

• next